Strategy-based cognitive intervention for Parkinson disease: A pilot randomizedcontrolled trial
Strategy-based cognitive intervention for Parkinson disease: A pilot randomizedcontrolled trial
批准号:
10444191
负责人:
ERIN R FOSTER
金额:
$13.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-15 至 2022-04-30
关键词:
AffectAgeAmericanAttenuatedBehavior TherapyBrain InjuriesClinical TrialsCognitiveDataDevelopmentDissemination and ImplementationEducational InterventionEducational process of instructingEffectivenessFutureGoalsImpaired cognitionInfrastructureInterventionIntervention StudiesLifeMedicalNeurodegenerative DisordersOperative Surgical ProceduresParkinson DiseaseParticipantPharmacological TreatmentPopulationPreparationProceduresPsychological TransferQuality of lifeRandomized Controlled TrialsReproducibilityResearchResearch DesignResearch PersonnelResearch PriorityRoleSample SizeSingle-Blind StudyStrokeTestingTrainingTraining TechnicsTranslationsWorkbaseclinical practicecognitive rehabilitationcognitive trainingcostdaily functioningdisabilityefficacy clinical trialevidence baseexperienceimprovednon-dementednovelpersonalized strategiesrecruitsocioeconomicsstandard of caretrial comparing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The long term goal of this work is to reduce disability among people with Parkinson disease (PD) by enabling
them to cope with cognitive decline so they can perform and participate in desired activities and roles. PD is
the second most prevalent neurodegenerative disease, affecting over 1 million Americans and causing
considerable personal and socioeconomic costs that are expected to rise as the population ages. Cognitive
impairment produces significant disability and reduced quality of life among non-demented people with PD.
Unfortunately, existing medical (i.e. surgical and pharmacological) treatments for PD do not prevent, treat, or
mitigate the negative functional consequences of cognitive impairment. As such, the development of new,
effective cognitive rehabilitation treatments for PD is a top research priority. The investigators have developed
a novel, individualized, strategy training intervention to attenuate cognitive decline and improve or maintain
daily function in PD (Strategy Training for Transfer, STRAIT). It involves teaching people to use targeted
compensatory or adaptive strategies in everyday life to work around or through cognitive challenges and
achieve functional goals. Strategy training is a practice standard for cognitive rehabilitation in brain injury and
stroke, but its application in PD is novel. Furthermore, STRAIT incorporates specific evidence-based training
techniques to support the transfer of strategy use and its benefits to real-world activities and contexts. This
explicit focus on generalization to daily function is critically lacking in cognitive rehabilitation approaches for
people with PD to-date. The current project objective is to test and optimize the intervention and study
procedures for future clinical trials and eventual translation into clinical practice. The study design is a single-
blind pilot randomized controlled trial (RCT) comparing STRAIT to a standard-of-care control (task-oriented
cognitive training). The research plan has three specific aims: Aim 1 will examine general feasibility (e.g.
recruitment, retention), Aim 2 will examine participant- and therapist-related aspects of treatment fidelity, and
Aim 3 will generate preliminary estimates of STRAIT’s effect on daily function to inform sample size
calculations for a definitive RCT. The results from this study will directly inform an R01 application for an RCT
to test STRAIT’s efficacy and/or effectiveness. It will also provide the investigators with critical data,
experience, and infrastructure to facilitate future efficiency, rigor, and reproducibility in clinical trials and
dissemination and implementation in real-world clinical practice. This work will meet the pressing need for
effective cognitive interventions for people with PD and will ultimately positively impact function and quality of
life in this population.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fresc.2023.1274191
发表时间:
2023
期刊:
FRONTIERS IN REHABILITATION SCIENCES
影响因子:
--
作者:
[Kang, Eunyoung, Foster, Erin R]
通讯作者:
Foster, Erin R
DOI:
10.3389/fpubh.2022.834473
发表时间:
2022
期刊:
FRONTIERS IN PUBLIC HEALTH
影响因子:
5.2
作者:
[Kang, Eunyoung, Foster, Erin R.]
通讯作者:
Foster, Erin R.
The Weekly Calendar Planning Activity to Assess Functional Cognition in Parkinson Disease.
评估帕金森病功能认知的每周日历计划活动。
DOI:
10.1177/15394492221104075
发表时间:
2022-10
期刊:
OTJR-OCCUPATIONAL THERAPY JOURNAL OF RESEARCH
影响因子:
1.4
作者:
[Foster, Erin R., Carson, Lisa, Jonas, Jill, Kang, Eunyoung, Doty, Tasha, Toglia, Joan]
通讯作者:
Toglia, Joan
Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms
-
批准号:10260416
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2020
-
负责人:ERIN R FOSTER
-
依托单位:
Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms
-
批准号:10661005
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2020
-
负责人:ERIN R FOSTER
-
依托单位:
Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms
-
批准号:10404667
-
项目类别:
-
资助金额:$45.69万
-
财政年份:2020
-
负责人:ERIN R FOSTER
-
依托单位:
COGNITIVE REHABILITATION FOR EVERYDAY EXECUTIVE DYSFUNCTION IN PARKINSON DISEASE
-
批准号:8412993
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2012
-
负责人:ERIN R FOSTER
-
依托单位:
COGNITIVE REHABILITATION FOR EVERYDAY EXECUTIVE DYSFUNCTION IN PARKINSON DISEASE
-
批准号:8224883
-
项目类别:
-
资助金额:$9.51万
-
财政年份:2012
-
负责人:ERIN R FOSTER
-
依托单位:
COGNITIVE REHABILITATION FOR EVERYDAY EXECUTIVE DYSFUNCTION IN PARKINSON DISEASE
-
批准号:8600303
-
项目类别:
-
资助金额:$9.79万
-
财政年份:2012
-
负责人:ERIN R FOSTER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: